FFM
TEVA icon

Forum Financial Management’s Teva Pharmaceuticals TEVA Stock Holding History

Forum Financial Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,183
Closed -$505K – 917
2025
Q4 		$505K Hold
16,183
– – 0.01% 466
2025
Q3 		$327K Hold
16,183
– – ﹤0.01% 691
2025
Q2 		$271K Sell
16,183
-1,935
-11% -$31.2K ﹤0.01% 728
2025
Q1 		$278K Hold
18,118
– – ﹤0.01% 633
2024
Q4 		$399K Buy
18,118
+7,748
+75% +$141K 0.01% 479
2024
Q3 		$187K Sell
10,370
-200
-2% -$3.5K ﹤0.01% 732
2024
Q2 		$172K Sell
10,570
-1,000
-9% -$15.4K ﹤0.01% 682
2024
Q1 		$163K Hold
11,570
– – ﹤0.01% 718
2023
Q4 		$121K Buy
+11,570
New +$108K ﹤0.01% 669
2023
Q1 		– Sell
-12,491
Closed -$114K – 640
2022
Q4 		$114K Hold
12,491
– – ﹤0.01% 569
2022
Q3 		$101K Hold
12,491
– – ﹤0.01% 519
2022
Q2 		$94K Hold
12,491
– – ﹤0.01% 556
2022
Q1 		$117K Hold
12,491
– – 0.01% 588
2021
Q4 		$100K Buy
+12,491
New +$113K 0.01% 639

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Forum Financial Management's TEVA Position: Q1 2026 in Review

Forum Financial Management sold out of Teva Pharmaceuticals (TEVA) in Q1 2026, closing a stake of 16,183 shares — an estimated $505K sold.

Forum Financial Management first reported a position in TEVA in Q4 2021 and held it in 14 quarters. The position peaked at $505K in Q4 2025. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Forum Financial Management reported no remaining Teva Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Forum Financial Management sold 16,183 Teva Pharmaceuticals shares in Q1 2026, an estimated $505K.
  • Forum Financial Management first reported a position in Teva Pharmaceuticals in Q4 2021 and held it in 14 quarters.
  • Forum Financial Management's Teva Pharmaceuticals position peaked at $505K in Q4 2025.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Forum Financial Management's 13F filing for Q1 2026, filed 23 Apr 2026.